Our Portfolio

Below is a graph that portrays the different stages of our drugs and the problems they aim to solve.

​

So far, we are looking at the indications of our novel therapeutic, ASX-100, in how it could help COVID-19 patients, but the drug could have indications to ARDS more generally. 

01

Current

Pipeline